Abstract:Infectious meningitis is a large public health concern, especially in children and immunocompromised patients. Although the epidemiology of meningitis has shown significant decline in past decades, partly due to the introduction of vaccines, outbreaks are still reported worldwide. Diagnosis of meningitis is of critical importance, and it is considered to be one of the most urgent of the microbiological medical emergencies. In order to improve the treatment strategy, various diagnostic methods have been develop… Show more
“…In the present study, only 20 cases of osteoarticular involvement were reported over 15 years review, which concurs with other previous surveys [ 6 , 8 ]. The reason behind the low-rate involvement of osteoarticular tissue in melioidosis might be attributed to the low blood supply to these locations comparing to other organs and, in parallel, the fact that the majority of melioidosis cases are bacteremic and affect mostly organs rich with blood supply such as liver, spleen, lungs and brain [ 34 , 35 ]. In another study performed in tropical Australia, the percentages of primary and secondary melioidotic septic arthritis among 536 confirmed cases were 2.4 % and 2.6 %, respectively [ 36 ].…”
BackgroundOver the last two decades, many epidemiological studies were performed to describe risks and clinical presentations of melioidosis in endemic countries.MethodsWe performed a retrospective analysis of 158 confirmed cases of melioidosis collected from medical records from 2001 to 2015 in Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia, in order to update the current status of melioidosis clinical epidemiology in this putatively high risk region of the country.ResultsPrincipal presentations in patients were lung infection in 65 (41.1 %), skin infection in 44 (27.8 %), septic arthritis/osteomyelitis in 20 (12.7 %) and liver infection in 19 (12.0 %). Bacteremic melioidosis was seen in most of patients (n = 121, 76.6 %). Focal melioidosis was seen in 124 (78.5 %) of patients and multi-focal melioidosis was reported in 45 (28.5 %) cases. Melioidosis with no evident focus was in 34 (21.5 %) patients. Fifty-four (34.2 %) patients developed septic shock. Internal organ abscesses and secondary foci in lungs and/or soft tissue were common. A total of 67 (41 %) cases presented during the monsoonal wet season. Death due to melioidosis was reported in 52 (32.9 %) patients, while relapses were occurred in 11 (7.0 %). Twelve fatal melioidosis cases seen in this study were directly attributed to the absence of prompt acute-phase treatment. Predisposing risk factors were reported in most of patients (n = 133, 84.2 %) and included diabetes (74.7 %), immune disturbances (9.5 %), cancer (4.4 %) and chronic kidney disease (11.4 %). On multivariate analysis, the only independent predictors of mortality were the presence of at least one co-morbid factor (OR 3.0; 95 % CI 1.1–8.4), the happening of septic shock (OR 16.5; 95 % CI 6.1–44.9) and age > 40 years (OR 6.47; 95 % CI 1.7–23.8).ConclusionsMelioidosis should be recognized as an opportunistic nonfatal infection for healthy person. Prompt early diagnosis and appropriate antibiotics administration and critical care help in improved management and minimizing risks for death.
“…In the present study, only 20 cases of osteoarticular involvement were reported over 15 years review, which concurs with other previous surveys [ 6 , 8 ]. The reason behind the low-rate involvement of osteoarticular tissue in melioidosis might be attributed to the low blood supply to these locations comparing to other organs and, in parallel, the fact that the majority of melioidosis cases are bacteremic and affect mostly organs rich with blood supply such as liver, spleen, lungs and brain [ 34 , 35 ]. In another study performed in tropical Australia, the percentages of primary and secondary melioidotic septic arthritis among 536 confirmed cases were 2.4 % and 2.6 %, respectively [ 36 ].…”
BackgroundOver the last two decades, many epidemiological studies were performed to describe risks and clinical presentations of melioidosis in endemic countries.MethodsWe performed a retrospective analysis of 158 confirmed cases of melioidosis collected from medical records from 2001 to 2015 in Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia, in order to update the current status of melioidosis clinical epidemiology in this putatively high risk region of the country.ResultsPrincipal presentations in patients were lung infection in 65 (41.1 %), skin infection in 44 (27.8 %), septic arthritis/osteomyelitis in 20 (12.7 %) and liver infection in 19 (12.0 %). Bacteremic melioidosis was seen in most of patients (n = 121, 76.6 %). Focal melioidosis was seen in 124 (78.5 %) of patients and multi-focal melioidosis was reported in 45 (28.5 %) cases. Melioidosis with no evident focus was in 34 (21.5 %) patients. Fifty-four (34.2 %) patients developed septic shock. Internal organ abscesses and secondary foci in lungs and/or soft tissue were common. A total of 67 (41 %) cases presented during the monsoonal wet season. Death due to melioidosis was reported in 52 (32.9 %) patients, while relapses were occurred in 11 (7.0 %). Twelve fatal melioidosis cases seen in this study were directly attributed to the absence of prompt acute-phase treatment. Predisposing risk factors were reported in most of patients (n = 133, 84.2 %) and included diabetes (74.7 %), immune disturbances (9.5 %), cancer (4.4 %) and chronic kidney disease (11.4 %). On multivariate analysis, the only independent predictors of mortality were the presence of at least one co-morbid factor (OR 3.0; 95 % CI 1.1–8.4), the happening of septic shock (OR 16.5; 95 % CI 6.1–44.9) and age > 40 years (OR 6.47; 95 % CI 1.7–23.8).ConclusionsMelioidosis should be recognized as an opportunistic nonfatal infection for healthy person. Prompt early diagnosis and appropriate antibiotics administration and critical care help in improved management and minimizing risks for death.
“…1 ). Meningitis may instigate necrosis, reduced CSF and blood flow, and malfunctioning of central nervous system (CNS)(Zueter and Zaiter 2015 ). Meningitis might be outcome of either infectious or non-infectious sources (Barani et al 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…Infectious meningitis is a severe CNS disorder which, as a result of microbial infection, causes inflammation of the meninges. Usually, this is induced through viruses and bacteria and occasionally via parasites and fungi (Zueter and Zaiter 2015 ). The viral infection in CNS produces inflammation in separate anatomical regions such as the meninges, brain parenchyma, and cranial nerves or in various areas at the same time.…”
Section: Introductionmentioning
confidence: 99%
“…An inflammatory spectrum known as meningoencephalitis can occur pathologically between these neighbouring anatomical regions (Wright et al 2019 ). Viral meningitis is generally prevalent in comparison to bacterial meningitis nevertheless it is comparatively less severe (Zueter and Zaiter 2015 ). Most cases of community-acquired aseptic meningitis are viral meningitis which is most frequently caused by enteroviruses (e.g., coxsackievirus, type 9 echovirus) (Ranson et al 2020 ) and enteroviruses (Zueter and Zaiter 2015 ).…”
Section: Introductionmentioning
confidence: 99%
“…Viral meningitis is generally prevalent in comparison to bacterial meningitis nevertheless it is comparatively less severe (Zueter and Zaiter 2015 ). Most cases of community-acquired aseptic meningitis are viral meningitis which is most frequently caused by enteroviruses (e.g., coxsackievirus, type 9 echovirus) (Ranson et al 2020 ) and enteroviruses (Zueter and Zaiter 2015 ). However, other causes include lymphocytic choriomeningitis, cytomegalovirus, herpes simplex and mumps virus (Ranson et al 2020 ).…”
Meningitis is an inflammation of the protective membranes called meninges and fluid adjacent the brain and spinal cord. The inflammatory progression expands all through subarachnoid space of the brain and spinal cord and occupies the ventricles. The pathogens like bacteria, fungi, viruses, or parasites are main sources of infection causing meningitis. Bacterial meningitis is a life-threatening health problem that which needs instantaneous apprehension and treatment.
Nesseria meningitidis
,
Streptococcus pneumoniae
, and
Haemophilus flu
are major widespread factors causing bacterial meningitis. The conventional drug delivery approaches encounter difficulty in crossing this blood-brain barrier (BBB) and therefore are insufficient to elicit the desired pharmacological effect as required for treatment of meningitis. Therefore, application of nanoparticle-based drug delivery systems has become imperative for successful dealing with this deadly disease. The nanoparticles have ability to across BBB via four important transport mechanisms, i.e., paracellular transport, transcellular (transcytosis), endocytosis (adsorptive transcytosis), and receptor-mediated transcytosis. In this review, we reminisce distinctive symptoms of meningitis, and provide an overview of various types of bacterial meningitis, with a focus on its epidemiology, pathogenesis, and pathophysiology. This review describes conventional therapeutic approaches for treatment of meningitis and the problems encountered by them while transmitting across tight junctions of BBB. The nanotechnology approaches like functionalized polymeric nanoparticles, solid lipid nanoparticles, nanostructured lipid carrier, nanoemulsion, liposomes, transferosomes, and carbon nanotubes which have been recently evaluated for treatment or detection of bacterial meningitis have been focused. This review has also briefly summarized the recent patents and clinical status of therapeutic modalities for meningitis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.